Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available clinicopathological parameters
Background: Colorectal carcinoma (CRC) is the most common malignancy of the gastrointestinal tract, representing an incredible health problem. It is essential to develop drugs against novel targets––involved in CRC tumorigenesis and progression––to improve the management of the disease. The aim of t...
Saved in:
Main Authors: | Asmaa E. Bedeer, Nehal Abd El-Ghaffar Heabah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-07-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijpm.ijpm_284_21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01) -
Role of ginsenoside Rg1 as a PPAR-γ activator in protecting against manganese-induced hepatotoxicity: Insights into the TLR4/MyD88/MAPK signaling pathway
by: Mengjing Zhao, et al.
Published: (2025-01-01) -
Molecular docking of ferulic acid, bakuchiol and niazirin on peroxisome proliferator-activated receptor gamma (PPAR-γ) as anti-diabetic agents
by: Anjar Hermadi Saputro, et al.
Published: (2024-08-01) -
Utilizing bioinformatics and machine learning to identify CXCR4 gene-related therapeutic targets in diabetic foot ulcers
by: Hengyan Zhang, et al.
Published: (2025-02-01) -
Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease
by: Ana R. Pérez, et al.
Published: (2025-02-01)